Replies to post #1185 on Cytokinetics, Inc. (CYTK)

[Solantey]

Anticipating a very positive conference call. Update on milestone payments and news about the progress of the drugs in the pipeline.

Current market cap: $160M versus potential milestone payments of over $1B plus royalties.

Expecting the share price to be above $6.00 on Wednesday. Better days ahead. :)

p.s. As was posted on Yahoo: "Shorting for pennies or buying for dollars."

GLTA